Back to Search
CHARLES O'SHAUGHNESSY, M.D.
M.D.
Interventional Cardiology Physician
NPI: 1831178003IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
35040861(OH)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
35040861(OH)
Education
UNIVERSITY OF TOLEDO COLLEGE OF MEDICINE
Class of 1976
Research & Publications (20)
TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.
PMID 19463432·JACC Cardiovasc Interv·2009
8-other
Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
PMID 18556716·Eur Heart J·2008
4-observational
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.
PMID 18420096·J Am Coll Cardiol·2008
4-observational
Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.
PMID 19463387·JACC Cardiovasc Interv·2008
4-observational
Invited article: development of high-field superconducting Ioffe magnetic traps.
PMID 18376990·Rev Sci Instrum·2008
8-other
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.
PMID 17448368·J Am Coll Cardiol·2007
3-trial
Contrasting roles of neuronal Msk1 and Rsk2 in Bad phosphorylation and feedback regulation of Erk signalling.
PMID 17663748·J Neurochem·2007
7-preclinical
Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain.
PMID 17477516·J Med Chem·2007
7-preclinical
The pancreatic polypeptide family and the migrating motor complex of the rat: differential effects in the duodenum and jejunum.
PMID 17113659·Regul Pept·2007
7-preclinical
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial).
PMID 17126651·Am J Cardiol·2006
4-observational
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
PMID 16531618·JAMA·2006
4-observational
The StarClose Vascular Closure System: interventional results from the CLIP study.
PMID 17039508·Catheter Cardiovasc Interv·2006
4-observational
Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.
PMID 16814645·J Am Coll Cardiol·2006
4-observational
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.
PMID 17174180·J Am Coll Cardiol·2006
4-observational
Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.
PMID 15837249·J Am Coll Cardiol·2005
3-trial
Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization.
PMID 16204741·J Invasive Cardiol·2005
4-observational
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
PMID 16160130·JAMA·2005
3-trial
Properties of neurons in the trigeminal nucleus caudalis responding to noxious dural and facial stimulation.
PMID 15885666·Brain Res·2005
4-observational
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.
PMID 15837248·J Am Coll Cardiol·2005
3-trial
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
PMID 15635110·N Engl J Med·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 125 E BROAD ST, SUITE 305
ELYRIA, OH 44035 - Phone
- (440) 414-9100
Quick Facts
- NPI
- 1831178003
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 50
- Publications
- 20
Are you this provider?
Claim Your Profile